Pharmaceutical Economics and Policy

27 works

Enhancing global access to cancer medicines
Javier Cortés, José Manuel Pérez-García, Antonio Llombart‐Cussac +13
Review articleEconomic and Financial Impacts of CancerCA A Cancer Journal for Clinicians20201 citations
ABI
Shortages and price variability of essential cytotoxic medicines for treating children with cancers
Yehoda M. Martei, Kotoji Iwamoto, Ronald D. Barr +2
ArticlePharmaceutical Economics and PolicyBMJ Global Health20201 citations
ABI
563 Long-term acceptance of nebivolol in idiopathic dilated cardiomyopathy patients
Т. А. Абдуллаев, Н. А. Курбанов, I. R. Bekbulatova +1
ArticleHeart Failure Treatment and ManagementEuropean Journal of Heart Failure Supplements20060 citations
ABI
A Status Report on the Health Care Sector in France
N. Lalitha, Samira Guennif
ArticlePharmaceutical Economics and PolicyJournal of Health Management20080 citations
ABI
The Politics and Strategy of Industry Self-Regulation: The Pharmaceutical Industry's Principles for Ethical Direct-to-Consumer Advertising as a Deceptive Blocking Strategy
Denis Arnold, James L. Oakley
ArticlePharmaceutical industry and healthcareJournal of Health Politics Policy and Law20130 citations
ABI
P767Efficacy and safety of switching simvastatin intolerant patients with coronary artery disease to rosuvastatin treatment
Aleksandr B. Shek, Р. Д. Курбанов, G J Abdullaeva +3
ArticleLipoproteins and Cardiovascular HealthEuropean Heart Journal20170 citations
ABI
PO432 Compliance With Drug Therapy In Relation to Acute Coronary Events (A Fragment of the Register RACSMI-Uz)
G. Nagaeva, S. Nagaev
ArticlePharmaceutical Economics and PolicyGlobal Heart20180 citations
ABI
PO433 Compliance With Drug Therapy In Relation to Acute Coronary Events (A Fragment of the Register RACSMI-Uz)
G. Nagaeva, S. Nagaev
ArticlePharmaceutical Economics and PolicyGlobal Heart20180 citations
ABI
Antimicrobial Medicines Consumption in Eastern Europeand Central Asia – An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action
Jane Robertson, Kotoji Iwamoto, Iris Hoxha +18
ArticleAntibiotic Use and ResistanceFrontiers in Pharmacology20190 citations
ABI
PCN252 QUALITY EVALUATION OF PHARMACOECONOMIC STUDIES IN RUSSIAN CANCER RESEARCH: AN OUTSIDE VIEW
S. Djalalov, Dilfuza Djalalova, Murray Krahn +2
ArticleHealth Systems, Economic Evaluations, Quality of LifeValue in Health20190 citations
ABI
O'zbekistonda farmasevtika sanoatining rivojlanishi
Sh. Yakubova
ArticlePharmaceutical Economics and PolicyОбщество и инновации20210 citations
ABI
Pharmacoeconomics and the Patients’ Compliance as an Essential part of Successful therapy of iron Deficiency Anemia.
Khodjieva Gulirano Sayfullaevna
ArticleHealth Systems, Economic Evaluations, Quality of LifeIndonesian Journal of Innovation Studies20220 citations
ABI
Sudden Spurt in Pediatric Patients with AKI in Uzbekistan: A Call for International Drug Quality Control and Pharmaceutical Legislation
Nodira Murtalibova, Sidharth Kumar Sethi, Rupesh Raina +2
ArticlePharmaceutical Quality and CounterfeitingKidney36020230 citations
ABI
AVAILABILITY AND COSTS OF MEDICINES FOR THE TREATMENT OF TUBERCULOSIS
Batirova Barchinoy Tadjimukhammadovna
ArticleTuberculosis Research and EpidemiologyInternational Journal of Medical Sciences And Clinical Research20240 citations
ABI
Content analysis of anticancer drugs of the pharmaceutical market of the republic of Uzbekistan
Шохиста Шарофиддин кизи Мелибоева, Мизроб Мавлонович Болтаев, Umida Narzulaeva
ArticlePharmaceutical Economics and PolicyBIO Web of Conferences20240 citations
ABI
Fınancıal sustaınabılıty and rısk in antı-agıng startups
Mehmet Mustafa Besirikli
ArticlePharmaceutical Economics and PolicyJournal of Forensic Accounting Profession20240 citations
ABI
Drug-drug interactions in clinical practice: a literature review and SWOT analysis
Valeriya O. Barysheva, О. S. Golikova, В. Г. Кудрина +1
Review articlePharmaceutical Practices and Patient OutcomesMedical Technologies Assessment and Choice20240 citations
ABI
Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies
Homie Razavi, Imam Waked, Huma Qureshi +97
ArticleHepatitis C virus researchJournal of Hepatology20250 citations
ABI
EXPERIMENTAL ESTIMATION OF THE EFFICIENCY OF NEW POLICY IN THE PHARMACEUTICAL INDUSTRY
Sokhibmalik Khomidov
ArticlePharmaceutical Economics and PolicyЭкономика и предпринимательство20250 citations
ABI
The Range of Medicines in The City of Samarkand: A Marketing Analysis
Makhmudova Maftuna Mehrojovna, Rayimqulova Ch.A.
ArticleEducational Management and QualityEuropean International Journal of Multidisciplinary Research and Management Studies20250 citations
ABI
Blood-pressure and cholesterol lowering therapy with polypill and separate drug, their comparative effectiveness in persons with hypertension and dyslipidemia
Shakhlo Fayzullaeva, Г А Хамидуллаева
ArticleMedication Adherence and ComplianceAtherosclerosis20250 citations
ABI
Validation of Kazakh and Russian Generic Drug Questionnaire
Zhandulla Nakipov, U. N. Musaev, Indira Smagylova +7
ArticlePharmaceutical Economics and PolicyMedical Journal of the Islamic Republic of Iran20250 citations
ABI
Comparative Analysis of the Efficacy of a Polypill and a Free Combination of Antihypertensive Drugs and Statins in the Context of an Individualized Treatment Strategy
Shakhlo S. Fayzullaeva, Gulnoz A. Khamidullaeva, Guzal Zh. Abdullaeva +2
ArticlePharmaceutical Economics and PolicyInternational Journal of Biomedicine20250 citations
ABI
STAGES OF DEVELOPMENT OF NEW MEDICINAL PRODUCTS
A.K. SADANOV, B.B. BAIMAKHANOVA, Z.Zh. TURLYBAYEVA +2
ArticlePharmaceutical Quality and CounterfeitingМИКРОБИОЛОГИЯ ЖӘНЕ ВИРУСОЛОГИЯ20250 citations
ABI
Rare diseases as a global priority: the CIS Orphan Forum and the path toward collaboration with BRICS
Nuriya Z. Musina, Ahmed Al Saidi, Ayman W. El-Hattab +27
ArticleGenomics and Rare DiseasesThe BRICS Health Journal20260 citations
ABI